Safer brain scans: no contrast needed for meningioma detection?

NCT ID NCT04113408

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether special MRI sequences (FABIR) can spot meningiomas without using gadolinium contrast dye, which can build up in the body after many injections. Researchers compared the new method to standard contrast MRI in 315 adults undergoing screening or follow-up for meningioma. The goal was to see if the dye-free approach is accurate enough to replace contrast scans, reducing long-term risks for patients who need repeated imaging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondation ophtalmique Adolphe de Rothschild

    Paris, Paris, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.